Melissa Gilbert-Ross

6PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 27, 2025
High PER1 expression is associated with STK11 mutation and clinical biomarkers of immunotherapy resistance in lung adenocarcinoma.

Rebecca E Parker, Leon McSwain, Wei Zhou

|Apr 12, 2025
Nanoparticle delivery of a prodrug-activating bacterial enzyme leads to anti-tumor responses.

Sebastian G Huayamares, Liming Lian, Regina Rab

|Aug 29, 2024
Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer.

Junghui Koo, Chang-Soo Seong, Rebecca E Parker

|Jul 03, 2023
Live-cell invasive phenotyping uncovers the ALK2/BMP6 iron homeostasis pathway as a therapeutic vulnerability in LKB1-mutant lung cancer.

Junghui Koo, Chang-Soo Seong, Rebecca E Parker

|Feb 07, 2023
Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesis.

Chang-Soo Seong, Chunzi Huang, Austin C Boese

|Jan 30, 2021
The level of oncogenic Ras determines the malignant transformation of Lkb1 mutant tissue in vivo.

Briana Rackley, Chang-Soo Seong, Evan Kiely

Pageof 1